Sign In
Buy BWAY
$14.04
-0.520 (-3.57%)
At Close: Jun 03, 2026
New Strong Sell Stocks for January 10th
09:02am, Tuesday, 10'th Jan 2023
BWAY, BWAY and AXL have been added to the Zacks Rank #5 (Strong Sell) List on January 10, 2023.
BrainsWay Ltd. (BWAY) Q3 2022 Results - Earnings Call Transcript
12:34pm, Wednesday, 16'th Nov 2022
BrainsWay Ltd. (NASDAQ:BWAY ) Q3 2022 Results Earnings Conference Call November 16, 2022 8:30 AM ET Company Participants Bob Yedid - Investor Relations, LifeSci Advisors Christopher von Jako - Preside
BrainsWay to Report Third Quarter Financial Results on November 16, 2022
08:00am, Wednesday, 02'nd Nov 2022
BURLINGTON, Mass. and JERUSALEM, Nov. 02, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation
BrainsWay to Present at the H.C. Wainwright Annual Global Investment Conference
09:00am, Wednesday, 31'st Aug 2022
BURLINGTON, Mass. and JERUSALEM, Aug. 31, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced and non-invasive treatment f
BrainsWay (BWAY) Stock Pops 10% on FDA Clearance News
11:15am, Monday, 29'th Aug 2022
Today, there's big news for BrainsWay (NASDAQ: BWAY ) and the company's stakeholders. Reportedly, the U.S. Food and Drug Administration (FDA) granted BrainsWay 510(k) clearance for a unique platform t
BrainsWay Ltd.'s (BWAY) CEO Christopher von Jako on Q2 2022 Results - Earnings Call Transcript
02:55pm, Wednesday, 10'th Aug 2022
BrainsWay Ltd. (NASDAQ:BWAY ) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ET Company Participants Bob Yedid – LifeSci Advisors Christopher von Jako – President and Chief Executive Off
BrainsWay to Report Second Quarter Financial Results on August 10, 2022
08:00am, Wednesday, 27'th Jul 2022
BURLINGTON, Mass. and JERUSALEM, July 27, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation
Brainsway Ltd. Sponsored ADR (BWAY) Upgraded to Strong Buy: Here's Why
02:00pm, Tuesday, 26'th Jul 2022
Brainsway Ltd. Sponsored ADR (BWAY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects.
Wall Street Analysts Believe Brainsway Ltd. Sponsored ADR (BWAY) Could Rally 159%: Here's is How to Trade
11:32am, Wednesday, 13'th Jul 2022
The average of price targets set by Wall Street analysts indicates a potential upside of 158.6% in Brainsway Ltd. Sponsored ADR (BWAY).
Brainsway Ltd. Sponsored ADR (BWAY) Stock Jumps 9.4%: Will It Continue to Soar?
06:10am, Wednesday, 13'th Jul 2022
Brainsway Ltd. Sponsored ADR (BWAY) saw its shares surge in the last session with trading volume being higher than average.
BrainsWay's Shares Look Attractive
02:10pm, Tuesday, 12'th Jul 2022
The company boasts state-of-the-art technology with multi-usable helmets for different indications and more indications likely to be approved. International sales are another growth opportunity where
BrainsWay to Present at the H.C. Wainwright 1st Annual Mental Health Conference
08:00am, Wednesday, 22'nd Jun 2022
BURLINGTON, Mass. and JERUSALEM, June 22, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation
BrainsWay's (BWAY) CEO Chris von Jako on Q1 2022 Results - Earnings Call Transcript
01:11pm, Wednesday, 11'th May 2022
BrainsWay Ltd. (NASDAQ:BWAY ) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Bob Yedid – LifeSci Advisors Chris von Jako – President and Chief Executive Officer Scot
BrainsWay's (BWAY) CEO Christopher von Jako on Q4 2021 Results - Earnings Call Transcript
02:05pm, Wednesday, 09'th Mar 2022
BrainsWay's (BWAY) CEO Christopher von Jako on Q4 2021 Results - Earnings Call Transcript
BrainsWay to Present at the 32nd Annual Oppenheimer Healthcare Conference
08:00am, Tuesday, 01'st Mar 2022
BURLINGTON, Mass. and JERUSALEM, March 01, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulatio
